Log in to save to my catalogue

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based...

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2462406193

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan

About this item

Full title

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan

Publisher

United States: Public Library of Science

Journal title

PloS one, 2020-11, Vol.15 (11), p.e0242429

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Elevated Renal cell carcinoma (RCC) risk has been associated with the use of several antihypertensive medications but has not yet been elucidated in the populations prescribed alpha-1 blockers that are commonly used in the treatment of hypertension and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS-BPH). The aim of...

Alternative Titles

Full title

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2462406193

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2462406193

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0242429

How to access this item